Published in Ocul Surf on April 01, 2010
Biology and pathogenesis of Acanthamoeba. Parasit Vectors (2012) 2.36
Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba. Graefes Arch Clin Exp Ophthalmol (2013) 0.86
Role of phospholipase A₂ (PLA₂) inhibitors in attenuating apoptosis of the corneal epithelial cells and mitigation of Acanthamoeba keratitis. Exp Eye Res (2013) 0.84
The cyclic AMP phosphodiesterase RegA critically regulates encystation in social and pathogenic amoebas. Cell Signal (2013) 0.84
Cytopathic effect of Acanthamoeba on human corneal fibroblasts. Mol Vis (2012) 0.79
Evaluation of inhibitory potential of some selective methanolic plants extracts on biological characteristics of Acanthamoeba castellanii using human corneal epithelial cells in vitro. Parasitol Res (2013) 0.79
Photochemotherapeutic strategy against Acanthamoeba infections. Antimicrob Agents Chemother (2015) 0.79
Cytotoxic activity and degradation patterns of structural proteins by corneal isolates of Acanthamoeba spp. Graefes Arch Clin Exp Ophthalmol (2014) 0.77
[Acanthamoeba keratitis]. Ophthalmologe (2013) 0.77
IL-17A-mediated protection against Acanthamoeba keratitis. J Immunol (2014) 0.76
Protease-activated receptor 2 (PAR2) is upregulated by Acanthamoeba plasminogen activator (aPA) and induces proinflammatory cytokine in human corneal epithelial cells. Invest Ophthalmol Vis Sci (2014) 0.76
Loop-mediated isothermal amplification targeting 18S ribosomal DNA for rapid detection of Acanthamoeba. Korean J Parasitol (2013) 0.75
The development of drugs against Acanthamoeba infections. Antimicrob Agents Chemother (2016) 0.75
Role of protease-activated receptors 2 (PAR2) in ocular infections and inflammation. Receptors Clin Investig (2015) 0.75
Acanthamoeba spp. in Contact Lenses from Healthy Individuals from Madrid, Spain. PLoS One (2016) 0.75
Sitting at the window to the world--ocular parasites. Wien Med Wochenschr (2014) 0.75
Cytotoxic effect of acriflavine against clinical isolates of Acanthamoeba spp. Parasitol Res (2012) 0.75
Pathobiology and Immunobiology of Acanthamoeba Keratitis: Insights from Animal Models . Yale J Biol Med (2017) 0.75
Sensitivity of Enzymatic Toxins from Corneal Isolate of Acanthamoeba Protozoan to Physicochemical Parameters. Curr Microbiol (2017) 0.75
Interaction Between Methicillin-Resistant Staphylococcus aureus (MRSA) and Acanthamoeba polyphaga. Curr Microbiol (2017) 0.75
Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev (2003) 6.67
Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol Rev (2006) 3.96
FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci U S A (1995) 3.51
The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol (1989) 3.46
The phosphotyrosine binding-like domain of talin activates integrins. J Biol Chem (2002) 2.97
Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect Immun (1990) 2.94
Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc Natl Acad Sci U S A (2003) 2.89
Acanthamoeba keratitis in non-contact lens wearers. Arch Ophthalmol (1990) 2.82
Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae. Nature (1988) 2.24
Tandem scanning confocal corneal microscopy in the diagnosis of suspected acanthamoeba keratitis. Ophthalmology (2006) 2.14
The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica. Annu Rev Microbiol (2002) 2.06
Epidemiological characteristics of a Chicago-area Acanthamoeba keratitis outbreak. Am J Ophthalmol (2006) 1.56
The pathophysiology of Acanthamoeba keratitis. Trends Parasitol (2006) 1.52
Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol (2006) 1.38
The small GTP-binding proteins, Rac and Rho, regulate cytoskeletal organization and exocytosis in mast cells by parallel pathways. Mol Biol Cell (1996) 1.36
Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol (1995) 1.36
Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Eye (Lond) (2003) 1.32
Acanthamoeba keratitis multiple states, 2005-2007. MMWR Morb Mortal Wkly Rep (2007) 1.30
Trends in contact lens-associated corneal ulcers. Cornea (1996) 1.27
Encystation in parasitic protozoa. Curr Opin Microbiol (2001) 1.26
Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels. FASEB J (2005) 1.25
Cloning and characterization of a novel mannose-binding protein of Acanthamoeba. J Biol Chem (2004) 1.25
In vitro destruction of nerve cell cultures by Acanthamoeba spp.: a transmission and scanning electron microscopy study. J Parasitol (1996) 1.25
Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci (1993) 1.20
Role of carbohydrate-mediated adherence in cytopathogenic mechanisms of Acanthamoeba. J Biol Chem (1998) 1.20
The role of the complement system in innate immunity. Immunol Res (2005) 1.19
RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. Exp Cell Res (2003) 1.16
Pathogenic Acanthamoeba spp secrete a mannose-induced cytolytic protein that correlates with the ability to cause disease. Infect Immun (2003) 1.14
Pathogenesis of Acanthamoeba keratitis: carbohydrate-mediated host-parasite interactions. Infect Immun (1997) 1.12
Effects of temperature, amebic strain, and carbohydrates on Acanthamoeba adherence to corneal epithelium in vitro. Infect Immun (1991) 1.07
Proteases as markers for differentiation of pathogenic and nonpathogenic species of Acanthamoeba. J Clin Microbiol (2000) 1.07
Glycosylation and the complement system. Chem Rev (2002) 1.06
Updates in Acanthamoeba keratitis. Eye Contact Lens (2007) 1.05
The role of contact lenses, trauma, and Langerhans cells in a Chinese hamster model of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (1993) 1.04
Characterization and pathogenic potential of a soil isolate and an ocular isolate of Acanthamoeba castellanii in relation to Acanthamoeba keratitis. Curr Eye Res (1992) 1.03
The immune response to Naegleria fowleri amebae and pathogenesis of infection. FEMS Immunol Med Microbiol (2007) 1.03
Alternate and classical pathway components of complement in the normal cornea. Arch Ophthalmol (1980) 1.02
Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group. Ophthalmology (1999) 1.02
Apoptosis as a mechanism of cytolysis of tumor cells by a pathogenic free-living amoeba. Infect Immun (1994) 1.02
Complement and complement regulatory proteins in human tears. Invest Ophthalmol Vis Sci (1997) 1.02
Effects of mannose on Acanthamoeba castellanii proliferation and cytolytic ability to corneal epithelial cells. Invest Ophthalmol Vis Sci (2003) 0.99
A role for a galactose lectin and its ligands during encystment of Entamoeba. J Eukaryot Microbiol (2001) 0.98
Biochemical characterization and functional studies of Acanthamoeba mannose-binding protein. Infect Immun (2005) 0.97
Bilateral acanthamoeba keratitis. Am J Ophthalmol (2008) 0.97
Roles for the galactose-/N-acetylgalactosamine-binding lectin of Entamoeba in parasite virulence and differentiation. Glycobiology (2005) 0.96
Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea (2001) 0.96
Confocal microscopy in early diagnosis of Acanthamoeba keratitis. J Refract Surg (2004) 0.96
The interaction of Acanthamoeba spp. with activated macrophages and with macrophage cell lines. J Eukaryot Microbiol (1998) 0.95
The GTP-binding protein RhoA mediates Na,K-ATPase exocytosis in alveolar epithelial cells. Mol Biol Cell (2003) 0.95
In vitro pathogenicity of Acanthamoeba is associated with the expression of the mannose-binding protein. Invest Ophthalmol Vis Sci (2006) 0.95
Exacerbation of Acanthamoeba keratitis in animals treated with anti-macrophage inflammatory protein 2 or antineutrophil antibodies. Infect Immun (2001) 0.95
Cryptosporidium p30, a galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro. J Biol Chem (2007) 0.94
Role of mucosal IgA in the resistance to Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (1998) 0.93
Systemic immune response to Acanthamoeba keratitis in the Chinese hamster. Ocul Immunol Inflamm (1997) 0.92
Resistance of Acanthamoeba species to complement lysis. J Parasitol (1998) 0.92
Comparison of specific activity and cytopathic effects of purified 33 kDa serine proteinase from Acanthamoeba strains with different degree of virulence. Korean J Parasitol (2006) 0.92
Role of contact lens wear, bacterial flora, and mannose-induced pathogenic protease in the pathogenesis of amoebic keratitis. Infect Immun (2005) 0.91
Non-contact lens related Acanthamoeba keratitis at a tertiary eye care center in south India: Implications for eye care programs in the region. Med Sci Monit (2003) 0.91
In vitro characterization of Acanthamoeba castellanii cytopathic effect. J Parasitol (1995) 0.91
Susceptibility of pathogenic and nonpathogenic Naegleria spp. to complement-mediated lysis. Infect Immun (1987) 0.90
Encystment of Acanthamoeba during incubation in multipurpose contact lens disinfectant solutions and experimental formulations. Eye Contact Lens (2008) 0.89
Regulation of Entamoeba invadens encystation and gene expression with galactose and N-acetylglucosamine. Mol Biochem Parasitol (1999) 0.89
Acanthamoeba keratitis in a 5-year-old boy without a history of contact lens usage. Cornea (2006) 0.88
Acanthamoeba: a difficult pathogen to evaluate and treat. Cornea (2004) 0.88
The immunobiology of Acanthamoeba keratitis. Springer Semin Immunopathol (1999) 0.87
Effect of immunization with the mannose-induced Acanthamoeba protein and Acanthamoeba plasminogen activator in mitigating Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (2007) 0.87
Anomalous estimation of protease molecular weights using gelatin-containing Sds-Page. Anal Biochem (1996) 0.87
Impact of oral immunization with Acanthamoeba antigens on parasite adhesion and corneal infection. Invest Ophthalmol Vis Sci (1998) 0.87
Crithidia fasciculata induces encystation of Entamoeba invadens in a galactose-dependent manner. J Parasitol (1998) 0.86
Cytopathogenicity of acanthamoeba, vahlkampfia and hartmannella: quantative & qualitative in vitro studies on keratocytes. J Infect (2003) 0.86
Effects of mutations in the cytoplasmic domain of integrin beta(1) to talin binding and cell spreading. Exp Cell Res (1999) 0.86
The role of the innate and adaptive immune responses in Acanthamoeba keratitis. Arch Immunol Ther Exp (Warsz) (2002) 0.85
Resistance of highly pathogenic Naegleria fowleri amoebae to complement-mediated lysis. Infect Immun (1989) 0.85
Oral immunization with Acanthamoeba castellanii mannose-binding protein ameliorates amoebic keratitis. Infect Immun (2006) 0.85
Overnight orthokeratology-associated microbial keratitis. Cornea (2005) 0.84
Alterations in protein expression and complement resistance of pathogenic Naegleria amoebae. Infect Immun (1992) 0.82
[Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)]. Rev Med Chil (2002) 0.81
Complement system and the eye. Adv Exp Med Biol (2006) 0.81
Membrane vesiculation of Naegleria fowleri amoebae as a mechanism for resisting complement damage. J Immunol (1994) 0.81
Acanthamoeba keratitis and contact lens wear: static or increasing problem? Eye Contact Lens (2007) 0.80
[Early clinical diagnosis of acanthamoeba keratitis. A study of 70 eyes]. Klin Monbl Augenheilkd (1996) 0.80
Parasites on the rise: a new epidemic of Acanthamoeba keratitis. Am J Ophthalmol (2007) 0.79
Role and significance of the complement system in mucosal immunity: particular reference to the human breast milk complement. Immunol Cell Biol (2001) 0.78
Acanthamoeba keratitis. Int Ophthalmol Clin (2007) 0.78
Intracorneal instillation of latex beads induces macrophage-dependent protection against Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (2006) 0.78
Milk components inhibit Acanthamoeba-induced cytopathic effect. Invest Ophthalmol Vis Sci (2008) 0.77
A mechanism of acquired resistance to complement-mediated lysis by Entamoeba histolytica. J Parasitol (1997) 0.76
Role of tear anti-acanthamoeba IgA in Acanthamoeba keratitis. Adv Exp Med Biol (2002) 0.76
Effect of human tears on acanthamoeba-induced cytopathic effect. Arch Ophthalmol (2008) 0.76
Acanthamoeba keratitis: 2007: a train wreck in slow motion. Eye Contact Lens (2007) 0.75